Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1995-7-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
333
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
183-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7791822-Arthritis, Rheumatoid,
pubmed-meshheading:7791822-Cyclosporine,
pubmed-meshheading:7791822-Disease Progression,
pubmed-meshheading:7791822-Drug Therapy, Combination,
pubmed-meshheading:7791822-Humans,
pubmed-meshheading:7791822-Methotrexate,
pubmed-meshheading:7791822-Prednisolone
|
pubmed:year |
1995
|
pubmed:articleTitle |
New perspectives on treating rheumatoid arthritis.
|
pubmed:publicationType |
Editorial,
Comment
|